What is MedRhythms?
MedRhythms operates at the intersection of neuroscience and digital therapeutics, specializing in Neurologic Music Therapy (NMT) to address complex recovery needs for patients suffering from brain injuries, strokes, and neurodegenerative conditions. Founded in 2015, the company has successfully bridged the gap between academic research and clinical application, providing measurable outcomes in sensorimotor, speech, and cognitive rehabilitation. By partnering with premier rehabilitation hospitals, MedRhythms has established a comprehensive service model that spans outpatient, in-home, and telehealth settings, effectively democratizing access to specialized neuro-recovery care. Their commitment to clinical excellence ensures that every intervention is grounded in the physiological connection between auditory stimuli and neural plasticity, setting a new standard for non-invasive therapeutic modalities in the modern medical landscape.
How much funding has MedRhythms raised?
MedRhythms has raised a total of $5.7M across 3 funding rounds:
Series A
$5.3M
Debt
$150K
Debt
$272K
Series A (2018): $5.3M, investors not publicly disclosed
Debt (2020): $150K led by PPP
Debt (2021): $272K supported by PPP
Key Investors in MedRhythms
PPP
Public-Private Partnership
Undisclosed Investor
An institutional backer focused on long-term value creation within the high-growth healthcare technology and digital therapeutics sector.
Undisclosed Investor
A strategic investment partner specializing in early-to-growth stage life sciences and medical innovation firms.
What's next for MedRhythms?
With the recent influx of capital, MedRhythms is poised to deepen its investment in clinical research and technological infrastructure. The strategic roadmap focuses on expanding the reach of its NMT interventions to a broader patient demographic while enhancing its digital delivery capabilities. As the company scales, it will likely prioritize the integration of its services into standard-of-care protocols within major hospital networks, further validating its efficacy in the competitive neurorehabilitation market. Future growth will be defined by the company's ability to maintain its clinical standards while navigating the complexities of the U.S. healthcare reimbursement landscape, ultimately aiming to become the definitive provider of music-based neurological recovery solutions.
See full MedRhythms company page
